Literature DB >> 10484339

Phosphoinositide 3-kinase is required for aldosterone-regulated sodium reabsorption.

B L Blazer-Yost1, T G Păunescu, S I Helman, K D Lee, C J Vlahos.   

Abstract

Aldosterone, a steroid hormone, regulates renal Na+ reabsorption and, therefore, plays an important role in the maintenance of salt and water balance. In a model renal epithelial cell line (A6) we have found that phosphoinositide 3-kinase (PI 3-kinase) activity is required for aldosterone-stimulated Na+ reabsorption. Inhibition of PI 3-kinase by the specific inhibitor LY-294002 markedly reduces both basal and aldosterone-stimulated Na+ transport. Further, one of the products of PI 3-kinase, phosphatidylinositol 3,4,5-trisphosphate, is increased in response to aldosterone in intact A6 monolayers. This increase occurs just before the manifestation of the functional effect of the hormone and is also inhibited by LY-294002. With the use of blocker-induced noise analysis, it has been demonstrated that inhibition of phosphoinositide formation causes an inhibition of Na+ entry in both control and aldosterone-pretreated cultures by reducing the number of open functional epithelial Na+ channels (ENaCs) in the apical membrane of the A6 cells. These novel observations indicate that phosphoinositides are required for ENaC expression and suggest a mechanism for aldosterone regulation of channel function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484339     DOI: 10.1152/ajpcell.1999.277.3.C531

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  32 in total

Review 1.  Regulation of the epithelial sodium channel by accessory proteins.

Authors:  Kelly Gormley; Yanbin Dong; Giuseppe A Sagnella
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 2.  Phosphoinositide lipid second messengers: new paradigms for transepithelial signal transduction.

Authors:  Bonnie L Blazer-Yost; Charity Nofziger
Journal:  Pflugers Arch       Date:  2004-12-22       Impact factor: 3.657

Review 3.  Physiologic regulation of the epithelial sodium channel by phosphatidylinositides.

Authors:  Oleh Pochynyuk; Vladislav Bugaj; James D Stockand
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-09       Impact factor: 2.894

Review 4.  Binding and direct activation of the epithelial Na+ channel (ENaC) by phosphatidylinositides.

Authors:  Oleh Pochynyuk; Qiusheng Tong; Alexander Staruschenko; James D Stockand
Journal:  J Physiol       Date:  2007-02-01       Impact factor: 5.182

Review 5.  Regulation of the epithelial sodium channel by membrane trafficking.

Authors:  Michael B Butterworth; Robert S Edinger; Raymond A Frizzell; John P Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-28

6.  SGK1 is not required for regulation of colonic ENaC activity.

Authors:  Rexhep Rexhepaj; Ferruh Artunc; Florian Grahammer; Omaima Nasir; Ciprian Sandu; Björn Friedrich; Dietmar Kuhl; Florian Lang
Journal:  Pflugers Arch       Date:  2006-08-08       Impact factor: 3.657

7.  Activation of mitogen-activated protein kinase (mitogen-activated protein kinase/extracellular signal-regulated kinase) cascade by aldosterone.

Authors:  Eunan Hendron; James D Stockand
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

Review 8.  Decoding epithelial signals: critical role for the epidermal growth factor receptor in controlling intestinal transport function.

Authors:  D F McCole; K E Barrett
Journal:  Acta Physiol (Oxf)       Date:  2008-10-28       Impact factor: 6.311

9.  Ion transport regulation by P2Y receptors, protein kinase C and phosphatidylinositol 3-kinase within the semicircular canal duct epithelium.

Authors:  Satyanarayana R Pondugula; Nithya N Raveendran; Daniel C Marcus
Journal:  BMC Res Notes       Date:  2010-04-14

10.  SGK1 activity in Na+ absorbing airway epithelial cells monitored by assaying NDRG1-Thr346/356/366 phosphorylation.

Authors:  S K Inglis; M Gallacher; S G Brown; N McTavish; J Getty; E M Husband; J T Murray; S M Wilson
Journal:  Pflugers Arch       Date:  2008-09-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.